Datagov Opendata Platform

The National Health Insurance Administration aims to strengthen the quality of medical care for patients with myocardial infarction by selecting evidence-based medical indicators for public disclosure, to serve as a reference for relevant disease treatment and healthcare quality; The indicators are divided into three categories based on the treatment period and quality aspects, including inpatient process assessment, assessment of continued medication after discharge, and outcome assessment. This includes the ratio of inpatients with acute myocardial infarction (AMI) who undergo LDL cholesterol testing during hospitalization, medication ratios for AMI patients during hospitalization, and at three, six, and nine months after discharge, emergency department visit rates within three days after discharge for the same primary diagnosis or related conditions, and unplanned readmission rates within fourteen days after discharge for the same primary diagnosis or related conditions.